

Wondering why Acetazolamide is hard to find at your pharmacy? Learn why supply can be limited in 2026, what's causing the issue, and what you can do.
You've got a prescription in hand, but your pharmacist says they don't have Acetazolamide in stock. It's a frustrating experience — and one that's become all too common for patients who depend on this medication for conditions like glaucoma, altitude sickness, or idiopathic intracranial hypertension.
The good news is that Acetazolamide isn't gone. But depending on where you live and which formulation you need, finding it can take a bit more effort than it used to. In this article, we'll explain what Acetazolamide is, why it's sometimes difficult to find, and what you can do to get your prescription filled.
Acetazolamide (brand names: Diamox and Diamox Sequels) is a carbonic anhydrase inhibitor — a type of medication that reduces the activity of an enzyme called carbonic anhydrase throughout the body. By blocking this enzyme, Acetazolamide decreases the production of certain fluids, including aqueous humor in the eye and cerebrospinal fluid in the brain.
Acetazolamide is FDA-approved to treat:
It's been on the market for decades and is available as a generic, making it one of the more affordable medications in its class. The typical dose ranges from 250 mg to 1,000 mg per day depending on the condition being treated.
There are several reasons why Acetazolamide may be difficult to locate at your pharmacy in 2026:
While generic Acetazolamide tablets (125 mg and 250 mg) are produced by several companies including Teva, Zydus, and Accord, the injectable form (500 mg vial) and the extended-release capsule (Diamox Sequels, 500 mg) have far fewer manufacturers. When even one supplier experiences a production delay, the ripple effects can leave pharmacies without stock.
The pharmaceutical supply chain has faced ongoing challenges in recent years. Raw material shortages, manufacturing quality issues, and transportation delays can all contribute to intermittent gaps in Acetazolamide availability — particularly for the IV formulation used in hospitals.
Acetazolamide isn't a blockbuster drug like a statin or blood pressure medication. It treats relatively specific conditions, which means pharmacies may not keep large quantities in stock. If your local pharmacy doesn't regularly fill Acetazolamide prescriptions, they may not have it on the shelf at all.
Acetazolamide is commonly prescribed for altitude sickness prevention, especially before ski season or mountain climbing trips. This can cause seasonal demand spikes that temporarily outpace supply in certain regions — particularly pharmacies near popular high-altitude destinations.
If your pharmacy can't fill your Acetazolamide prescription, don't panic. Here are some practical steps:
As of early 2026, Acetazolamide oral tablets are not listed on the FDA or ASHP drug shortage lists. However, the injectable formulation has experienced intermittent shortages in prior years due to limited manufacturers. Even when a drug isn't officially in shortage, individual pharmacies may still have trouble sourcing it from their specific distributors.
For the latest updates on Acetazolamide availability, check out our Acetazolamide shortage update for 2026.
Acetazolamide is an important medication for many patients, and difficulty finding it can be stressful — especially when you need it to manage conditions like glaucoma or intracranial hypertension. The key is to stay proactive: use tools like Medfinder, explore alternative pharmacies, and keep your doctor in the loop about any access issues.
If you're looking for ways to save money while searching, our guide on how to save money on Acetazolamide covers coupons, discounts, and patient assistance options.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.